# Astellas vs Daiichi Sankyo vs Otsuka Holdings vs Takeda

> Unit: JPY millions (ratios in %)
> Periods: Astellas = FY ending Mar 2024, consolidated, IFRS / Daiichi Sankyo = FY ending Mar 2024, consolidated, IFRS / Otsuka Holdings = FY ending Dec 2023, consolidated, IFRS / Takeda = FY ending Mar 2024, consolidated, IFRS
> Retrieved: 2026-09-30T20:42:09.968Z

| Metric | Astellas | Daiichi Sankyo | Otsuka Holdings | Takeda |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 1,603,672 | 1,601,688 | 2,018,568 | 4,263,762 |
| Operating income | — | — | — | — |
| Net income | 17,045 | 200,731 | 121,616 | 144,067 |
| COGS ratio | — | — | — | — |
| Operating margin | — | — | — | — |
| Net margin | 1.1% | 12.5% | 6.0% | 3.4% |
| FCF margin | — | — | — | — |
| Period | FY ending Mar 2024 | FY ending Mar 2024 | FY ending Dec 2023 | FY ending Mar 2024 |
| Source | S100YBPK | S100YZB3 | S100XUA7 | S100YB5L |

## Five-axis industry profile

Each axis shows a rank within that company's primary industry, so peer groups may differ. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

| Axis | Astellas | Daiichi Sankyo | Otsuka Holdings | Takeda |
| --- | ---: | ---: | ---: | ---: |
| Revenue growth | — | — | — | — |
| Profitability | — | — | — | — |
| Cash conversion | — | — | — | — |
| Efficiency | 39.1 (32 peers) | 42.2 (32 peers) | 70.3 (32 peers) | 1.6 (32 peers) |
| Financial strength | — | — | — | — |

## Company details

- https://vizora.meequs.com/en/company/astellas-pharma/md
- https://vizora.meequs.com/en/company/daiichi-sankyo/md
- https://vizora.meequs.com/en/company/otsuka-holdings/md
- https://vizora.meequs.com/en/company/takeda-pharmaceutical/md

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).